SYS-CON MEDIA Authors: Elizabeth White, Mat Mathews, PR.com Newswire, David Smith, Tim Crawford

News Feed Item

NeoStrata® Introduces ProSystem Peels Bringing Together Customizable Options for Superficial Peeling in One Complete System

PRINCETON, N.J., March 24, 2014 /PRNewswire/ -- NeoStrata Company, Inc., the originators of professional glycolic acid peels, introduces NeoStrata® ProSystem Peels, a complete Alpha Hydroxy Acid (AHA) superficial peeling system created to give physicians customizable options for skin rejuvenation treatments that can be tailored to meet individual patient needs. This new introduction was unveiled last week at the 2014 American Academy of Dermatology (AAD) winter academy meeting in Denver, CO.

NeoStrata ProSystem Peels provide treatment flexibility with four Rejuvenating Glycolic Acid peels at 20%, 35%, 50% and 70% concentrations plus two targeted benefit peels in an all-in-one system that features the company's unique free acid, low pH formulations. The targeted Clarifying peel (30% Mandelic and Citric Acids) is ideal for oily and acne prone skin, while the Brightening peel (30% Citric Acid) can be used for uneven skin tone and hyperpigmentation.  These peels can be used alone, in a series, layered or in combination with a variety of other professional treatments including microdermabrasion, dermaplaning, injectables and laser/light therapies. NeoStrata ProSystem peels are ideal for patients with multiple skin rejuvenation concerns including rough texture, fine lines, wrinkles, discolorations, blemishes, keratosis pilaris, and pseudofolliculitis barbae.

"Chemical peels play an essential role in skin rejuvenation and are consistently in the top 5 non-invasive cosmetic procedures performed in physician offices," said M. Elizabeth Briden, MD, Adjunct Associate Clinical Professor of Medicine at the University of Minnesota Medical School. "Now, with the clinically-proven skin rejuvenation benefits of three Alpha Hydroxy Acids in one complete system, physicians can uniquely customize patient skincare treatment plans for any skin type."

NeoStrata founders Drs. Eugene Van Scott and Ruey Yu were the pioneers in Alpha Hydroxy Acid technology and introduced physicians and patients to the breakthrough antiaging effects of AHAs.  NeoStrata ProSystem builds on the company's heritage as a leader in AHAs and also includes Balancing Pre-Peel Cleanser and Foaming Peel Neutralizer. Additionally, NeoStrata offers a full line of complementary products for patients pre-peel, post-peel and for home care in its Resurface, Restore and Skin Active segments of products. NeoStrata ProSystem Peels are available exclusively through physician offices. 

"Skin rejuvenation requires a stepped, customizable approach and NeoStrata ProSystem is designed with that in mind," said Barbara Green, RPh, Vice-President of Clinical Affairs at NeoStrata.  "This new introduction leverages our company's scientific leadership in Alpha Hydroxy Acid technology and provides an important option for professionals seeking to optimize patient aesthetic results either alone or in combination with other procedures and home care."

About NeoStrata

NeoStrata Company, Inc., headquartered in Princeton NJ, develops and markets a comprehensive range of clinically-proven, dermatologist-developed skin care products.  The company was founded in 1988 by Drs. Eugene Van Scott and Ruey Yu, world renowned leaders in dermatology and dermato-pharmacology whose proud medical heritage includes decades of clinical research and numerous patents. NeoStrata's advanced therapeutic and cosmetic dermatological products feature patented unsurpassed Alpha Hydroxy and Polyhydroxy Acids plus Acetyl Amino Acid and Sugar technologies to meet the needs of every skin type and are available worldwide through physicians' offices, consumer outlets and spas.

SOURCE NeoStrata Company, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.